Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiation therapy in the locoregional treatment of triple-negative breast cancer.

The Lancet. Oncology - 1 Mar 2015

Moran Meena S

Abstract excerpt

This Review assesses the relevant data and controversies regarding the use of radiotherapy for, and locoregional management of, women with triple-negative breast cancer (TNBC). In view of the strong association between BRCA1 and TNBC, knowledge of baseline mutation status can be useful to guide locoregional treatment decisions. TNBC is not a contraindication for breast conservation therapy because data suggest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Support Techniques
Share to Mastectomy
Share to Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Patient Selection

Share to Predictive Value of Tests

Share to Radiation Tolerance

Share to Radiotherapy, Adjuvant

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 25752562
DOI: 10.1016/S1470-2045(14)71104-0

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiation therapy in the locoregional treatment of triple-negative breast cancer.PMID 25752562Read ↗

Radiation therapy for triple-negative breast cancer: from molecular insights to clinical perspectives.Semantic proximity Read ↗

Triple Negative Breast Cancer Patients Treated with Radiation Therapy: Improvement in Survival and Local Control With Adjuvant Chemotherapy Compared To Neoadjuvant Chemotherapy – A Hypothesis Generating ReportSemantic proximity Read ↗

Triple Negative Breast Cancer Treatment Options and Limitations: Future OutlookSemantic proximity Read ↗

Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.Semantic proximity Read ↗

Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?Semantic proximity Read ↗

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Semantic proximity Read ↗

Targeted Therapies for Triple-Negative Breast Cancer.Semantic proximity Read ↗

Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes.Semantic proximity Read ↗

[Genetic bases of the radiosensitivity of breast cancer].Semantic proximity Read ↗

Advances in the systemic treatment of triple-negative breast cancer.Semantic proximity Read ↗

The triple-negative subtype: new ideas for the poorest prognosis breast cancer.Semantic proximity Read ↗

Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline VariantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.